# Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants

> **NCT06206811** · PHASE1 · COMPLETED · sponsor: **Odyssey Therapeutics** · enrollment: 101 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Blau Syndrome
- Crohn Disease
- Ulcerative Colitis
- Spondyloarthritis

## Interventions

- **DRUG:** OD-07656

## Key facts

- **NCT ID:** NCT06206811
- **Lead sponsor:** Odyssey Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-12
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06206811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06206811, "Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06206811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*